why choose us

First received: March 12, 2024

Clinical Trial: JETi Hong Kong Post Market Study (PMS)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Peripheral Venous Thrombosis

Study Type: OBSERVATIONAL


Official Title: JET Enhanced Thrombectomy Intervention Hong Kong Post Market Study

Brief Summary: The JETi Hong Kong PMS is a single-arm, multicenter study to collect real-world data on the safety, performance, and clinical benefits of the JETi System for the treatment of acute and subacute thrombosis in the peripheral vasculature.This is a post-market study that will register approximately 20 subjects at approximately 5 centers in Hong Kong.Subjects participating in this study will be followed for up to 30 days (in cases of prospective consent) after Day 0. Day 0 is defined as the day when the JETi catheter…

Read more